{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:11:00Z","timestamp":1770689460431,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00296-017-3852-9","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T18:45:24Z","timestamp":1508438724000},"page":"267-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["IGRA testing in patients with immune-mediated inflammatory diseases: which factors influence the results?"],"prefix":"10.1007","volume":"38","author":[{"given":"Juan","family":"Gonz\u00e1lez-Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Garc\u00eda-Gasalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s","family":"Losada-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Cifuentes Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Mir Viladrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Fern\u00e1ndez-Baca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araceli","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Juan Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Riera-Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Payeras Cifre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"3852_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","volume":"55","author":"SS Jick","year":"2006","unstructured":"Jick SS, Lieberman ES, Rahman MU et al (2006) Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 55:19\u201326","journal-title":"Arthritis Rheum"},{"key":"3852_CR2","first-page":"1436","volume":"30","author":"L Carmona","year":"2003","unstructured":"Carmona L, Hern\u00e1ndez-Garc\u00eda C, Vadillo C, EMECAR Study Group et al (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30:1436\u20131439","journal-title":"J Rheumatol"},{"key":"3852_CR3","first-page":"41","volume":"91","author":"F Iannone","year":"2014","unstructured":"Iannone F, Cantini F, Lapadula G (2014) Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations. J Rheumatol 91:41\u201346","journal-title":"J Rheumatol"},{"key":"3852_CR4","first-page":"24","volume":"91","author":"D Goletti","year":"2014","unstructured":"Goletti D, Sanduzzi A, Delogu G (2014) Performance of the tuberculin skin test and interferon-\u03b3 release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches. J Rheumatol 91:24\u201331","journal-title":"J Rheumatol"},{"key":"3852_CR5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/s10165-009-0226-5","volume":"20","author":"T Maeda","year":"2010","unstructured":"Maeda T, Banno S, Maeda S et al (2010) Usefulness and limitations of QuantiFERON-TB Gold in Japanese rheumatoid arthritis patients: proposal to decrease the lower cutoff level for assessing latent tuberculosis infection. Mod Rheumatol 20:18\u201323","journal-title":"Mod Rheumatol"},{"key":"3852_CR6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0961203310397966","volume":"20","author":"N Takeda","year":"2011","unstructured":"Takeda N, Nojima T, Terao C et al (2011) Interferon-gamma release assay for diagnosing Mycobacterium tuberculosis infections in patients with systemic lupus erythematosus. Lupus 20:792\u2013800","journal-title":"Lupus"},{"key":"3852_CR7","doi-asserted-by":"crossref","first-page":"297e1","DOI":"10.1016\/j.eimc.2010.02.006","volume":"28","author":"J Gonz\u00e1lez-Mart\u00edn","year":"2010","unstructured":"Gonz\u00e1lez-Mart\u00edn J, Garc\u00eda-Garc\u00eda JM, Anibarro L et al (2010) Consensus document on the diagnosis, treatment and prevention of tuberculosis. Enferm Infecc Microbiol Clin 28:297e1\u2013297e120","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"3852_CR8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.00107608","volume":"33","author":"F Bartalesi","year":"2009","unstructured":"Bartalesi F, Vicidomini S, Goletti D et al (2009) QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 33:586\u2013593","journal-title":"Eur Respir J"},{"key":"3852_CR9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","volume":"67","author":"G Matulis","year":"2008","unstructured":"Matulis G, J\u00fcni P, Villiger PM et al (2008) Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 67:84\u201390","journal-title":"Ann Rheum Dis"},{"key":"3852_CR10","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ibd.21605","volume":"17","author":"E B\u00e9lard","year":"2011","unstructured":"B\u00e9lard E, Semb S, Ruhwald M et al (2011) Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm Bowel Dis 17:2340\u20132349","journal-title":"Inflamm Bowel Dis"},{"key":"3852_CR11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/0961203316639381","volume":"25","author":"H Cho","year":"2016","unstructured":"Cho H, Kim YW, Suh CH et al (2016) Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA. Lupus 25:1341\u20131348","journal-title":"Lupus"},{"key":"3852_CR12","first-page":"1427","volume":"13","author":"O Shovman","year":"2009","unstructured":"Shovman O, Anouk M, Vinnitsky N et al (2009) QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study. Int J Tuberc Lung Dis 13:1427\u20131432","journal-title":"Int J Tuberc Lung Dis"},{"key":"3852_CR13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-2362.2011.02502.x","volume":"41","author":"P Papay","year":"2011","unstructured":"Papay P, Eser A, Winkler S et al (2011) Predictors of indeterminate IFN-\u03b3 release assay in screening for latent TB in inflammatory bowel diseases. Eur J Clin Investig 41:1071\u20131076","journal-title":"Eur J Clin Investig"},{"key":"3852_CR14","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00296-014-3033-z","volume":"34","author":"HJ Jung","year":"2014","unstructured":"Jung HJ, Kim TJ, Kim HS et al (2014) Analysis of predictors influencing indeterminate whole-blood interferon-gamma release assay results in patients with rheumatic diseases. Rheumatol Int 34:1711\u20131720","journal-title":"Rheumatol Int"},{"key":"3852_CR15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1183\/09031936.00075008","volume":"33","author":"Y Kobashi","year":"2009","unstructured":"Kobashi Y, Sugiu T, Mouri K et al (2009) Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 33:812\u2013815","journal-title":"Eur Respir J"},{"key":"3852_CR16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","volume":"56","author":"A Cattamanchi","year":"2011","unstructured":"Cattamanchi A, Smith R, Steingart KR et al (2011) Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 56:230\u2013238","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3852_CR17","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1128\/JCM.01054-12","volume":"50","author":"MC Aichelburg","year":"2012","unstructured":"Aichelburg MC, Tittes J, Breitenecker F et al (2012) Prognostic value of indeterminate IFN-\u03b3 release assay results in HIV-1 infection. J Clin Microbiol 50:2767\u20132769","journal-title":"J Clin Microbiol"},{"key":"3852_CR18","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1128\/CVI.00166-12","volume":"19","author":"T Oni","year":"2012","unstructured":"Oni T, Gideon HP, Bangani N et al (2012) Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment. Clin Vaccine Immunol 19:1243\u20131247","journal-title":"Clin Vaccine Immunol"},{"key":"3852_CR19","doi-asserted-by":"crossref","first-page":"e1441","DOI":"10.1371\/journal.pone.0001441","volume":"3","author":"F Karam","year":"2008","unstructured":"Karam F, Mbow F, Fletcher H et al (2008) Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV\/AIDS progression. PLoS ONE 3:e1441","journal-title":"PLoS ONE"},{"key":"3852_CR20","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","volume":"190","author":"M Sester","year":"2014","unstructured":"Sester M, van Leth F, Bruchfeld J, TBNET et al (2014) Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med 190:1168\u20131176","journal-title":"Am J Respir Crit Care Med"},{"key":"3852_CR21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00018-005-5390-y","volume":"63","author":"MJ Herold","year":"2006","unstructured":"Herold MJ, McPherson KG, Reichardt HM (2006) Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 63:60\u201372","journal-title":"Cell Mol Life Sci"},{"key":"3852_CR22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.crohns.2011.09.011","volume":"6","author":"U Helwig","year":"2012","unstructured":"Helwig U, M\u00fcller M, Hedderich J et al (2012) Corticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patients. J Crohns Colitis 6:419\u2013424","journal-title":"J Crohns Colitis"},{"key":"3852_CR23","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/ard.2009.113829","volume":"69","author":"S Kleinert","year":"2010","unstructured":"Kleinert S, Kurzai O, Elias J et al (2010) Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases. Ann Rheum Dis 69:782\u2013784","journal-title":"Ann Rheum Dis"},{"key":"3852_CR24","first-page":"776","volume":"35","author":"D Ponce de Leon","year":"2008","unstructured":"Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S et al (2008) Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 35:776\u2013781","journal-title":"J Rheumatol"},{"key":"3852_CR25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/ard.2008.101857","volume":"69","author":"J Martin","year":"2010","unstructured":"Martin J, Walsh C, Gibbs A et al (2010) Comparison of interferon gamma release assays and conventional screening tests before tumour necrosis factor alpha blockade in patients with inflammatory arthritis. Ann Rheum Dis 69:181\u2013185","journal-title":"Ann Rheum Dis"},{"key":"3852_CR26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MPG.0000000000000205","volume":"58","author":"O Hradsky","year":"2014","unstructured":"Hradsky O, Ohem J, Zarubova K et al (2014) Disease activity is an important factor for indeterminate interferon-\u03b3 release assay results in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 58:320\u2013324","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3852_CR27","doi-asserted-by":"crossref","first-page":"e0119260","DOI":"10.1371\/journal.pone.0119260","volume":"10","author":"H Lee","year":"2015","unstructured":"Lee H, Park HY, Jeon K et al (2015) QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment. PLoS ONE 10:e0119260","journal-title":"PLoS ONE"},{"key":"3852_CR28","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1136\/annrheumdis-2011-200408","volume":"71","author":"X Mariette","year":"2012","unstructured":"Mariette X, Baron G, Tubach F et al (2012) Influence of replacing tuberculin skin test with ex vivo interferon \u03b3 release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy. Ann Rheum Dis 71:1783\u20131790","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3852-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3852-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3852-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T11:48:02Z","timestamp":1516276082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3852-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["3852"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3852-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}